Skip to content

Efficacy and safety of diluted epinephrine saline irrigation for safe removal in patients with external ventricular drainage: a prospective, single-center, randomized controlled trial

A novel approach to safe removal of external ventricular drainage: an exploratory study of diluted epinephrine saline irrigation

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600129558
Enrollment
Unknown
Registered
2026-08-06
Start date
2026-08-15
Completion date
Unknown
Last updated
2026-08-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intracerebral hemorrhage

Interventions

Intervention group:Diluted epinephrine saline irrigation

Sponsors

Changsha Central Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Age >= 18 years and <= 75 years, irrespective of gender; 2. Patients who have undergone external ventricular drainage for therapeutic indications (e.g., intracerebral hemorrhage, hydrocephalus, etc.) and are planned for bedside extubation of the ventricular catheter; 3. Written informed consent has been obtained from the patient or their legally authorized representative.

Exclusion criteria

Exclusion criteria: 1.Hypersensitivity to epinephrine or any of its excipients; 2. Uncorrectable coagulopathy or thrombocytopenia prior to extubation, defined as INR > 1.5, or platelet count < 75 × 10^9/L; 3. Malposition of the ventricular catheter with the tip failing to reach the ventricular cavity, resulting in absent or inadequate cerebrospinal fluid drainage, thus making diluted epinephrine saline irrigation inapplicable; 4. Active hemorrhage along the puncture route or within the ventricular system, or a marked increase in intracranial hematoma volume on pre-extubation CT; 5. Concurrent severe comorbidities that might confound the assessment of safety and efficacy, or a life expectancy of less than 48 hours; 6. Family decision to withdraw active treatment and request tube removal for transfer or discharge, with refusal of routine post-extubation head CT; 7. Pregnancy or lactation; 8. Adrenal disorders; 9. History of malignant cardiac arrhythmias, including ventricular fibrillation, sustained ventricular tachycardia, and Wolff-Parkinson-White syndrome.

Design outcomes

Primary

MeasureTime frame
Incidence of hemorrhage after drain removal;Incidence of intracranial infection after drain removal;Vital signs after drain removal;

Secondary

MeasureTime frame
Rate of secondary intervention due to rebleeding after drain removal;Incidence of headache after drain removal;Incidence of nausea and vomiting after drain removal;

Countries

China

Contacts

Public ContactHuang Yunfeng

Changsha Central Hospital

1033475315@qq.com+86 731 85668064

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Aug 25, 2026